The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(Benzylsulfonyl)-1-(3-cyano-5-oxo-6,7-dihydro-5H-pyrrolo-[3,4-b]pyridin-2-yl)piperidine-4-carboxamide ID: ALA5286497
Max Phase: Preclinical
Molecular Formula: C21H21N5O4S
Molecular Weight: 439.50
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1cc2c(nc1N1CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC1)CNC2=O
Standard InChI: InChI=1S/C21H21N5O4S/c22-11-16-10-17-18(12-23-21(17)28)24-19(16)26-8-6-15(7-9-26)20(27)25-31(29,30)13-14-4-2-1-3-5-14/h1-5,10,15H,6-9,12-13H2,(H,23,28)(H,25,27)
Standard InChI Key: JRKMDCOUGBAABY-UHFFFAOYSA-N
Molfile:
RDKit 2D
31 34 0 0 0 0 0 0 0 0999 V2000
39.7947 -13.4465 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.3903 -12.7408 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
38.9813 -13.4439 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.4414 -11.5135 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.1511 -11.1041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1483 -10.2814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4397 -9.8762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8572 -11.5108 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.8565 -12.3289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5608 -12.7363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2702 -12.3301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2709 -11.5119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5621 -11.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8522 -9.8690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5584 -9.4577 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.9770 -12.7402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9752 -13.5574 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.6857 -12.3332 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.1011 -12.3363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.8079 -12.7465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.8014 -13.5631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.5073 -13.9732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.2169 -13.5661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.2161 -12.7447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.5095 -12.3383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7309 -11.1063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7375 -10.2850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9585 -10.0248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4703 -10.6854 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.9477 -11.3537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7123 -9.2456 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
26 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 27 1 0
8 9 1 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
5 8 1 0
14 15 3 0
6 14 1 0
11 16 1 0
16 17 2 0
16 18 1 0
18 2 1 0
2 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
26 27 2 0
27 28 1 0
28 29 1 0
29 30 1 0
30 26 1 0
28 31 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 439.50Molecular Weight (Monoisotopic): 439.1314AlogP: 1.06#Rotatable Bonds: 5Polar Surface Area: 132.26Molecular Species: ACIDHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.98CX Basic pKa: 1.34CX LogP: 0.85CX LogD: -0.09Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.71Np Likeness Score: -1.32
References 1. Kong D, Xue T, Guo B, Cheng J, Liu S, Wei J, Lu Z, Liu H, Gong G, Lan T, Hu W, Hu W, Yang Y.. (2019) Optimization of P2Y12 Antagonist Ethyl 6-(4-((Benzylsulfonyl)carbamoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate (AZD1283) Led to the Discovery of an Oral Antiplatelet Agent with Improved Druglike Properties., 62 (6.0): [PMID:30843696 ] [10.1021/acs.jmedchem.8b01971 ]